The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Cholesterol Reduction and the Risk for Stroke in Men: A Meta-Analysis of Randomized, Controlled Trials
Abstract
OBJECTIVE: Reducing serum cholesterol lowers the risk for ischemic heart disease, but its effects on other vascular diseases are unknown. Published trials were reviewed to determine the effect of cholesterol-lowering interventions on fatal and nonfatal stroke. DESIGN: Meta-analysis of randomized, controlled trials. DATA IDENTIFICATION: A literature search of English-language studies examining the effect of modified diets or medications on cardiovascular end points from 1965 to 1992 using MEDLINE and a review of references of five quantitative overviews of cholesterol reduction and coronary disease. DATA ANALYSIS: Thirteen studies met three eligibility criteria: patients randomized to intervention or control; fatal or nonfatal stroke reported separately; and end points assessed without knowledge of treatment status. Heterogeneity among studies and overall effects of treatment on fatal and nonfatal stroke were estimated using the Mantel-Haenszel-Peto method to combine independent study results. The influence of various study designs and interventions was explored using subgroup comparisons. RESULTS: For fatal stroke, the overall odds ratio associated with cholesterol-lowering interventions in 13 trials was 1.32 (95% Cl, 0.94 to 1.86), and the odds ratio for the 10 single-intervention trials was 1.34 (Cl, 0.91 to 1.96). Among eight trials reporting nonfatal events, the summary odds ratio for nonfatal stroke for treated participants compared with controls was 0.88 (Cl, 0.70 to 1.11), and the odds ratio for total strokes was 0.98 (Cl, 0.80 to 1.19). Among three trials using clofibrate, treatment significantly increased the risk for fatal stroke (odds ratio, 2.64; Cl, 1.42 to 4.92) but not for nonfatal stroke (odds ratio, 0.87; Cl, 0.61 to 1.26). Regression analysis showed no statistical association between the magnitude of cholesterol reduction and the risk for fatal stroke. CONCLUSIONS: Lowering serum cholesterol through modified diets or medications does not reduce stroke mortality or morbidity in middle-aged men. Clofibrate appears to increase the risk for fatal strokes, but the mechanism for this effect is unknown.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Test of effect of lipid lowering by diet on cardiovascular risk. The Minnesota Coronary Survey.
Frantz, I. D., Dawson, E. A., Ashman, P. L., Gatewood, L. C., Bartsch, G. E., Kuba, K., & Brewer, E. R. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.1.129 · Cited by 293
Cited by
Goldstein, L. B., Adams, R., Becker, K., Furberg, C. D., Gorelick, P. B., Hademenos, G., Hill, M., Howard, G., Howard, V. J., Jacobs, B., et al. (2001) · Stroke · doi:10.1161/01.str.32.1.280 · Cited by 905
(1995) · The Lancet · doi:10.1016/s0140-6736(95)92836-7 · Cited by 856
Hebert, P. R. (1997) · JAMA · doi:10.1001/jama.1997.03550040069040 · Cited by 740
Biller, J., Feinberg, W. M., Castaldo, J. E., Whittemore, A. D., Harbaugh, R. E., Dempsey, R. J., Caplan, L. R., Kresowik, T. F., Matchar, D. B., Toole, J. F., et al. (1998) · Stroke · doi:10.1161/01.str.29.2.554 · Cited by 658
Moore, W. S., Barnett, H. J. M., Beebe, H. G., Bernstein, E. F., Brener, B. J., Brott, T., Caplan, L. R., Day, A., Goldstone, J., Hobson, R. W., et al. (1995) · Stroke · doi:10.1161/01.str.26.1.188 · Cited by 545
Metadata
- Authors
- Atkins, D., Psaty, B. M., Koepsell, T. D., Longstreth, W. T., & Larson, E. B.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 1993-07-15
- Volume
- 119
- Issue
- 2
- Pages
- 136-145
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2075077540
- Cited by
- 212
- References
- 1
- FWCI
- 19.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cholesterol Reduction and the Risk for Stroke in Men: A Meta-Analysis of Randomized, Controlled Trials. https://app.cochat.ai/papers/10.7326/0003-4819-119-2-199307150-00008
- The paper
- Atkins, D., Psaty, B. M., Koepsell, T. D., Longstreth, W. T., & Larson, E. B. (1993). Cholesterol Reduction and the Risk for Stroke in Men: A Meta-Analysis of Randomized, Controlled Trials. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-119-2-199307150-00008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.